Reviva Pharmaceuticals Holdings Investor Relations Material
Latest events
Study Result
Reviva Pharmaceuticals Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Reviva Pharmaceuticals Holdings Inc
Access all reports
Reviva Pharmaceuticals Holdings Inc. is a biopharmaceutical company focused on developing therapies for central nervous system (CNS) and respiratory diseases. The company specializes in small-molecule drug candidates targeting conditions such as schizophrenia, bipolar disorder, depression, and pulmonary arterial hypertension. The company is headquartered in Cupertino, California, and its shares are listed on the NASDAQ.
Key slides for Reviva Pharmaceuticals Holdings Inc
Study Result
Reviva Pharmaceuticals Holdings Inc
Study Result
Reviva Pharmaceuticals Holdings Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RVPH
Country
🇺🇸 United States